ERBB2 and breast carcinoma: A study in breast cancer showed that CAR-CD147 targeting HER2 macrophages, which were activated after HER2 recognition to trigger the internal signaling of CD147 and increase the expression of MMPs, did not affect proliferation of tumor cells in vitro.